Quick Answer
Protagonist Therapeutics, Inc reported Total Assets of $668.19 million for fiscal year 2025.
Protagonist Therapeutics, Inc Total Assets — Annual History
| Fiscal Year | Total Assets | YoY Change |
|---|---|---|
| 2025 | $668.19M | -10.3% |
| 2024 | $744.73M | +108.1% |
| 2023 | $357.95M | +44.4% |
| 2022 | $247.93M | -28.7% |
| 2021 | $347.69M | +7.2% |
| 2020 | $324.47M | +109.4% |
| 2019 | $154.92M | +11.1% |
| 2018 | $139.47M | -14.8% |
| 2017 | $163.73M | +74.2% |
| 2016 | $93.99M | +533.1% |
| 2015 | $14.85M | — |
Quarterly Total Assets
| Quarter Ending | Total Assets | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $701.69M | +16.2% | -2.3% |
| June 30, 2025 | $718.01M | +16.8% | -3.3% |
| March 31, 2025 | $742.13M | +17.9% | -0.3% |
| December 31, 2024 | $744.73M | +108.1% | +23.3% |
| September 30, 2024 | $603.86M | +83.0% | -1.8% |
| June 30, 2024 | $614.63M | +91.8% | -2.3% |
| March 31, 2024 | $629.28M | +162.4% | +75.8% |
| December 31, 2023 | $357.95M | +44.4% | +8.5% |
- Protagonist Therapeutics, Inc showed a decrease of -10.3% in Total Assets compared to the prior fiscal year.
- Over the 2015–2025 period, Protagonist Therapeutics, Inc’s total assets has grown by 4401.1% (from $14.85 million to $668.19 million).
- The most recent figure is from Protagonist Therapeutics, Inc’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 25, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: